Christopher P. Cannon

Author

Also Known As

Christopher P. Cannon

Publications

232

Citations

H-Index

Concepts

All Affiliations

Christopher P. Cannon is an author at Brigham and Women's Hospital specializing in cardiovascular disease, medicine, and thrombosis.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	161
2	Pharmacology	2	2	101
3	Emergency Medicine	1	1	60
4	Clinical Pharmacology	1	1	19
5	Clinical Trials	1	1	19

Christopher P. Cannon

Publications

175

Citations

H-Index

Page 1

	Year	Citations
Anticoagulant effects of hirulog, ∗∗Hirulog™ brand direct thrombin inhibitor. a novel thrombin inhibitor, in patients with coronary artery disease Christopher P. Cannon, John M. Maraganore, Joseph Loscalzo, The American Journal of Cardiology ThrombosisCardiovascular DiseaseBlood PlateletMedicineAnticoagulant Effects	1993	82
NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease Payal Kohli, Philippe Gabríel Steg, Christopher P. Cannon, The American Journal of Medicine Stable Atherothrombotic DiseaseThrombosisCardiovascular DiseaseMedicinePharmacotherapy	2013	60
Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials Christopher P. Cannon Clinical Cardiology Cardiovascular PharmacologyPharmacotherapyAcute Myocardial InfarctionMolecular PharmacologyThrombosis	2000	19
Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition Daniel P. Marcusa, Robert P. Giugliano, Jeong‐Gun Park, JAMA Cardiology	2020	14

Page 1